Total Funding
61
77
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5728
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.
- Avi Veidman: CEO
- Ori Zelichov: VP Clinical DevelopmentPast Role: Fore Biotherapeutics, Medical Director
About the Company
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,
licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Middle Eastern / North African Founded
